BridgeMD
New treatment option for Guillain-Barré Syndrome
Official title RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome
ClinicalTrials.gov ID: NCT05461898
What this study is testing
- What it's testing
- Guillain-Barré syndrome (GBS) is a neurological disease characterized by an inflammation of peripheral nerves, which might be responsible for long-term disability. Respiratory muscle weakness is a complication of GBS and might be responsible for respiratory symptoms, inadequate secretion clearance or hypoventilation, with negative impact on daily life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ≥18 years
- diagnosed with Guillain Barré Syndrome
- willing to participate in an inpatient rehabilitation program
- able to provide informed consent
You likely can't join if
- presence of significant cardiac and musculoskeletal diseases
- tracheostomized patients
- signs of cognitive impairment or current neoplastic or immunological disease which may preclude their participation in the rehabilitation program and...
The study team makes the final eligibility decision.
Where it's taking place
- Vila Nova de Gaia, Portugal
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vila Nova de Gaia, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.